Revollo R, Tinajeros F, Hilari C, García SG, Zegarra L, Díaz-Olavarrieta C, Conde-González CJ

Language: Spanish
References: 24
Page: 422-428
PDF size: 196.62 Kb.

ABSTRACT

Objective. Assess frequencies of maternal and congenital syphilis, mother-child transmission and variables associated with syphilis in six urban hospitals in Bolivia. Material and Methods. A cross-sectional study was performed between May and September 2004. We administered the Abbot Determine- TP rapid test and quantitative RPR to postpartum women without prior RPR. Sociodemographic variables and prior prenatal care visits were studied. Newborns of syphilis positive mothers were studied with Western Blot IgM p47 and ELISA IgM. Serum samples were analyzed at the Central Reference Laboratory (INLASA). Statistical analysis included bivariate and multivariate analyses to establish association with positive diagnosis of T. pallidum. Results. Syphilis prevalence among 1 594 postpartum women was 7.2%. Mother to child transmission was 15.7%. Congenital syphilis prevalence by serology was 1.1% and 94% of these newborns displayed no symptoms. Despite 70.5% prenatal care coverage in Bolivia some women still go directly to a facility to give birth without prior routine tests for syphilis. Low education levels in both parents (‹ 8 years) and failure to attend prenatal care were strong predictors of congenital syphilis. Conclusions. Rapid syphilis tests constitute an important tool to strengthen early diagnosis of syphilis during pregnancy. Preventing congenital and maternal syphilis in Bolivia remains a public health priority.

REFERENCES

1. Watts DH, Brunham RC. Sexually transmitted diseases, including HIV infection in pregnancy. En: Holmes KK, Sparling PF, Mardh P-A, et al, eds. Sexually transmitted diseases. 3a edición. Nueva York: McGraw Hill, 1999:1100-1102.

2. Population Council. Reproductive Health and Family Planning. Reproductive Tract Infections, Pregnancy and Children. Disponible en: http://www.org/rhfp/rti_fact_sheets/preg.html.

3. Organización Panamericana de la Salud. Eliminación de la sífilis congénita en América Latina y el Caribe. Marco de referencia para su implementación. Washington, D.C.: OPS, 2005.

4. Terris-Prestholt F, Watson-Jones D, Mugeye K, Kumaranayake L, Ndeki L, Weiss H, et al. Is antenatal syphilis screening still cost effective in sub- Saharan Africa? Sex Transm Infect 2003; 79:375-381.

5. Broutet N. Eliminating congenital syphilis: A global health priotity. 9th International Union against Sexually Transmitted Infections (IUSTI), World Congress; 2005 nov 15-18; Bangkok, Thailand.

6. Southwick K, Blanco S, Santander A, Estensoro M, Torrico F, Seoane G, et al. Congenital and maternal syphilis in Bolivia, 1996: Prevalence and risk factors. Bull World Health Organ 2001; 79:33-42.

7. Sato NS, de Melo CS, Zerbini LCMS, Silveira EPR, Fagundes LJ, Ueda M. Assessment of the rapid test based on an immunochromatography technique for detecting anti-Treponema pallidum antibodies. Rev Inst Med Trop S Paulo 2003; 45:319-322.

8. Diaz T, Almeida MGB, Georg I, Maia SC, de Souza RV, Markowitz LE. Evaluation of the Determine rapid syphilis TP assay using sera. Clin Diagn Lab Immunol. 2004; 11:98-101.

9. Hernández-Trejo M, Hernández-Prado B, Uribe-Salas F, Juárez-Figueroa L, Conde-González CJ. Sífilis materna y congénita en dos hospitales mexicanos: evaluación de una prueba diagnóstica rápida. Rev Invest Clin 2006; 58: 119-125.

10. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2002. MMWR 2002; 51 (RR-6):1-78.

11. Centers for Disease Control and Prevention. Guidelines for prevention and control of congenital syphilis. MMWR. 1988; 37 (No. S-1).

12. Reynolds SL, Kapadia AS, Leonard L, Ross MW. Examining the direct costs and effectiveness of syphilis detection by selective screening and partner notification. J Public Health Med 2001; 23:339-345.

13. Sistema Nacional de Información en Salud SNIS. Ministerio de Salud y Deportes. www.sns.gov.bo.

14. Tinajeros F, Grossman D, Richmond K, Steele M, Garcia SG, Zegarra L, et al. Diagnostic accuracy of a point-of-care syphilis test when used among pregnant women in Bolivia. Sex Transm Infect 2006; 82(suppl 5): v17-v21.

15. García SG, Tinajeros F, Revollo R, Yam EA, Richmond K, Díaz- Olavarrieta C, et al. Demonstrating public health at work: a demonstration project of congenital syphilis prevention efforts in Bolivia. Sex Transm. Dis 2007; 34(Suppl 7): S37-S41.

16. Jenniskens F, Obwaka E, Kirisuah S, Moses S, Yusufali FM, Achola JO, et al. Syphilis control in pregnancy: decentralization of screening facilities to primary care level, a demonstration project in Nairobi, Kenya. Int J Gynaecol Obstetric 1995; 48 (suppl):S121-S128.

17. Sison CG, Ostrea EM Jr, Reyes MP, Salari V. The resurgence of congenital syphilis: a cocaine-related problem. J Pediatric 1997; 130: 289-292.

18. Barsanti C, Valdetaro F, de Alburquerque DEM, Succi RC. Diagnostic of congenital syphilis: a comparison between serological tests in mothers and their newborns. Rev Soc Bras Med Trop 1999; 32:605-611.

19. Sombié I, Meda N, Cartoux M, Tiendrébéogo S, Ouangré A, Yaro S, et al. Seroprevalence of syphilis among women attending urban antenatal clinics in Burkina Faso, 1995-8. Sex Transm Inf 2000; 76:314-316.

20. Juárez FLA, Meléndez BLA, Conde GC. Hallazgo de sífilis a término del embarazo en mujeres de Cuernavaca, Mor. Rev Inv Clin 2001; 53:375-377.

21. Noyola DE, Malacara-Alfaro O, Lima-Rogel V, Torres-Montes A. Seroprevalencia de sífilis en mujeres embarazadas en San Luis Potosí. Salud Publica Mex 2006; 48:151-154.

22. Encuesta Nacional de Demografía en Salud. ENDSA 2003. Instituto Nacional de Estadística de Bolivia. INE. www.ine.gov.bo.

23. Instituto Nacional de Estadística de Bolivia. INE. www.ine.gov.bo.

24. Joint United Nations Programme on HIV/AIDS. Consultation on STD interventions for preventing HIV: what is the evidence? Geneva: 2000 (UNAIDS/03.04E).